Stryker shrugs off recall charges in Q4 to end 2012 on target

January 24, 2013 by MassDevice staff

Medical device company Stryker Corp. gives back ⅓ of its profits on charges related to the 4th-quarter recall of its Rejuvenate and ABG II modular-neck hip stems, but manages to top analyst estimates nonetheless.


Orthopedic giant Stryker (NYSE:SYK) reported a nearly 33% drop in net income for the 4th quarter on expected charges related to the Rejuvenate and ABG II modular-neck hip stems recall but the company managed to end 2012 strong.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.